Investing-News.Com
Information for Investors

DUSA PHARM INC, (DUSA) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

DUSA PHARM INC, (DUSA) Stock Rating Learn More

Our Overall Rating on DUSA Pharmaceuticals Inc,  DUSA is STRONG SELL
StockPickReport.Com research suggests DUSA's price will move significantly lower than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

Both stochastic and "relative strength" indicators point to a move down.

Investors, traders, and other market participants may find this a good opportunity to sell DUSA, "sell calls", or "buy puts".

This may also be an opportunity to lower targets and raise stop/losses to protect capital.

Trading volume seems to be falling and DUSA's closing price moved up during the week before this rating was initiated.

Our STRONG SELL Rating on DUSA was issued on 03/25/08

DUSA PHARM INC Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces DUSA PHARM INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in DUSA PHARM INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on DUSA PHARM INC. This software is specially designed to give precision entry and exit points on DUSA PHARM INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When DUSA PHARM INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even DUSA PHARM INC, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: annual report  software stock swing trader trading  no load fund analyst  www.nates notes.com 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

DUSA PHARMACEUTICALS INC Financials (EDGAR Online Financials)

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference (Marketwire)

Q3 2008 DUSA Pharmaceuticals Earnings Release - Before Market Open (CCBN)

DUSA Pharmaceuticals Reports Third Quarter 2008 Corporate Highlights and Financial Results (Marketwire)

DUSA Pharmaceuticals, Inc. Announces Third Quarter Financial Results and Corporate Highlights Conference Call (Marketwire)

DUSA PHARMACEUTICALS INC Files SEC form 8-K, Other Events (EDGAR Online)

UPDATE - Dusa to stop developing acne treatment; shares fall (at Reuters)

DUSA Announces Results for Phase IIB Trial Of Levulan(R) Photodynamic Therapy for Moderate to Severe Acne (Marketwire)

Coverage initiated on DUSA Pharma by Rodman & Renshaw (Briefing.com)

Zacks #1 Rank Additions for Wednesday (Zacks.com)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.